HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper View responses Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (16) Citing Articles via Google Scholar Google Scholar Articles by Ballot, E. Articles by Johanet, C. Search for Related Content PubMed PubMed Citation Articles by Ballot, E. Articles by Johanet, C. Related Collections Clinical Immunology Proteomics and Protein Markers

Identification of Rat Targets of Anti-Soluble Liver Antigen Autoantibodies by Serologic Proteome Analysis

¹ Service d’Immunologie et Hématologie Biologiques and
² Service de Biochimie A, Hôpital Saint-Antoine, AP-HP, 75012 Paris, France.

³ Laboratoire de Neurobiologie et Diversité Cellulaire, Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris 75005, France.

^aAddress correspondence to this author at: Service d’Immunologie, Hôpital Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France. Fax 33-1-49-28-30-46; e-mail catherine.johanet{at}sat.ap-hop-paris.fr.

Background: Anti-soluble liver antigen (SLA) autoantibodies are specific for autoimmune hepatitis type 1 and are the only immunologic marker found in 15–20% of hepatitis cases previously considered cryptogenic. Anti-SLA antibodies react with the 100 000g supernatant from rat liver homogenate, but the molecular targets remain controversial.

Methods: We characterized anti-SLA targets by one- and two-dimensional immunoblotting analysis. The recognized proteins were identified by peptide mass fingerprint analysis after matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry.

Results: Three proteins of 35 kDa and pI 6.0, 50 kDa and pI between 6.0 and 6.5, and 58 kDa and pI between 6.5 and 7.0 were stained more intensely by anti-SLA positive-sera than by control sera. After in-gel tryptic digestion, MALDI-TOF analysis of the generated peptides enabled the clear identification of N-hydroxyarylamine sulfotransferase, isoforms of -enolase, and isoforms of catalase.

Conclusions: Possible antigens for anti-SLA antibodies include a sulfotransferase, -enolase(s), and catalase(s). Two-dimensional electrophoresis combined with mass spectrometry offers a versatile tool to identify molecular targets of autoantibodies and thus to improve diagnostic tools and the understanding of the immune process.

The following articles in journals at HighWire Press have cited this article:

				T. Chitlaru, O. Gat, H. Grosfeld, I. Inbar, Y. Gozlan, and A. Shafferman Identification of In Vivo-Expressed Immunogenic Proteins by Serological Proteome Analysis of the Bacillus anthracis Secretome Infect. Immun., June 1, 2007; 75(6): 2841 - 2852. [Abstract] [Full Text] [PDF]

				D.-P. Bogdanos, I. Bianchi, Y. Ma, R. R. Mitry, G. Mieli-Vergani, D. Vergani, E. Ballot, A. Bruneel, and C. Johanet Targets of Antibodies to Soluble Liver Antigen in Patients with Autoimmune Hepatitis * Drs. Ballot, Bruneel, and Johanet respond: Clin. Chem., March 1, 2004; 50(3): 682 - 684. [Full Text] [PDF]

				A. W. Purcell and J. J. Gorman Immunoproteomics: Mass Spectrometry-based Methods to Study the Targets of the Immune Response Mol. Cell. Proteomics, March 1, 2004; 3(3): 193 - 208. [Abstract] [Full Text] [PDF]

eLetters: